April 20 Italy’s Ministry of Civil Defence reported 8,864 new confirmed cases and 316 deaths on Thursday, Euronews reported. As of 18:00 on the 19th, the country has confirmed a total of 3878994 cases, 117,243 deaths and 3268,262 cured cases.
Italian Prime Minister Mario Draghi reportedly announced last week that a yellow outbreak surveillance zone would be restored from April 26. The government will approve the new law this week, but there are still many problems to be resolved before it is formally enacted.
At present, the Italian government cabinet is discussing the reduction of curfew time and other issues. Mr Draghi said the government had chosen to take reasonable risks based on the data to loosen the control of the outbreak. In fact, the reduction in restrictions is bound to increase the risk of deaths.
Italy’s reopening could be costly, according to an article published in the journal Nature Medicine. The team combined a variety of controls and vaccination factors to predict a variety of different scenarios using mathematical models.
The results showed that 298,000 people would die between April this year and January next year without vaccines and effective drugs;
Meanwhile, the government’s decision to reopen all schools since 26 April has caused concern across the community. In fact, schools in many places, from Milan in the north to Rome in the centre to Palermo in the south, have expressed concern about reopening schools.
Giannelli, head of Italy’s National Association of Head Teachers, said 75 percent of faculty members had completed the first dose of the vaccine. It is impossible to fully secure a safe distance for all students to return to school now. Schools still have the option of continuing to arrange online and offline classes, allowing students to take turns attending school.
Mr Hinnopolis, general secretary of the National School Union, said there was no real support for the government’s resumption of hardware for centralized teaching. Before deciding to reopen schools 100 per cent, vaccination programmes should be promptly promoted, safety protocols updated, and vaccinators sampled and tracked to assess actual results, otherwise school safety would not be guaranteed.
Italy’s National Science and Technology Commission, the University of Milan immunologist Sergio 19, said the Italian Medicines Agency (Aifa) may be in October this year to approve the vaccination of minors in Coronavirus vaccine plan.
Sergio noted that Italy is likely to get the first test data on Coronavirus vaccine for minors by June. He expressed optimism about the data and hoped that they would be approved by the relevant departments in a timely manner. If all goes well, Italy could begin vaccinating young children and adolescents between October and November.
